FDA alert: Thousands of bottles of blood pressure pills recalled over possible dissolution failure
FILE - A doctor reads a blood pressure gauge during an examination of patient. (Photo by Joe Raedle/Getty Images)
A nationwide recall has been issued for thousands of bottles of blood pressure medication due to a manufacturing issue, according to an alert from the U.S. Food and Drug Administration.
Dig deeper:
Inventia Healthcare Limited, which is based in India, initiated the voluntary recall of Chlorthalidone Tablets USP, 25 mg, on June 5.
By the numbers:
Approximately 11,460 bottles have been recalled, according to the FDA.
The recall involves 100-count and 1000-count bottles that were distributed by Risiong Pharma Holdings, Inc., in New Jersey.
Why you should care:
The pills did not pass "dissolution specifications," which basically means they don’t dissolve effectively when it enters the body.
The recalls involves the following bottles of medication:
- 100 tablet bottles: Batch # RISA24001
- 1000 tablet bottles: Batch RISB24002
Both should have an expiration date of April 2027.
The Source: Information for this article was taken from an FDA alert. This story was reported from San Jose.